Cargando…
Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis
AIM: Cystic fibrosis (CF) patients are at high risk of developing CF-related diabetes (CFRD). In non-CF patients, liver disease, specifically steatosis and non-alcoholic fatty liver disease (NAFLD), is strongly associated with type 2 diabetes. We compared glycemic status and metabolic profiles in CF...
Autores principales: | Colomba, Johann, Netedu, Silvia R., Lehoux-Dubois, Catherine, Coriati, Adèle, Boudreau, Valérie, Tremblay, François, Cusi, Kenneth, Rabasa-Lhoret, Rémi, Leey, Julio A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6638946/ https://www.ncbi.nlm.nih.gov/pubmed/31318914 http://dx.doi.org/10.1371/journal.pone.0219855 |
Ejemplares similares
-
Impact of 1h oral glucose tolerance test on the clinical status of adult cystic fibrosis patients over a 4-year period
por: Boudreau, Valérie, et al.
Publicado: (2021) -
Glucose tolerance in Canadian and French cystic fibrosis adult patients
por: Reynaud, Quitterie, et al.
Publicado: (2019) -
The Potential Causes of Cystic Fibrosis-Related Diabetes
por: Coderre, Lise, et al.
Publicado: (2021) -
Adrenal Insufficiency in Cystic Fibrosis: A Rare Phenomenon?
por: Préville-Ratelle, Sébastien, et al.
Publicado: (2018) -
The Benefits and Limits of Technological Advances in Glucose Management Around Physical Activity in Patients Type 1 Diabetes
por: Tagougui, Sémah, et al.
Publicado: (2019)